| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 670163 | Null | 0.0152619242759634 | 0.00037795972 |
| NSC 675253 | Null | 0.0152619242759634 | 0.41701924 |
| NSC 689529 | Null | 0.0152619242759634 | 0.54171322 |
| NSC 696661 | (6R,6S)-2,4-Diamino-6-(3,4,5-trimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline | 0.0152619242759636 | 0.36249504 |
| NSC 700325 | Null | 0.0152619242759636 | 0.30023618 |
| NSC 728509 | 1-(2-Benzylthio-4-chloro-5-phenylcarbamoylbenzenesulfonyl)-3 -(2-oxobutane-3-ylideneimino)guanidine | 0.0152619242759636 | 0.30570139 |
| NSC 760289 | 3-hydroxy-8,9-dimethoxy-isoindolo[2,1a]quinoxalin-6-(5H)-imino | 0.0152619242759636 | 0.35053017 |
| NSC 107124 | Camptothecin Derivative | 0.0179905510964914 | 0.48762477 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0179905510964914 | 0.13544984 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0179905510964914 | 0.41699925 |